Fibro Relief
- Manufacturer
- Apotheca Company
- Effective date
- 2011-04-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:08
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Ferrum metallicum 30C, Guaiacum 30C, Lithium carbonicum 30C, Lycopersium esculentum 30C, Magnesia phosphorica 30C.
OTC - PURPOSE SECTION
USES: For relief of fibromyalgia symptoms.
WARNINGS SECTION
WARNINGS: Do not use if tamper-resistant seal is broken.
Do not take if pregnant or nursing.
Stop use and ask a doctor is symptoms continue or get worse, or if new symptoms occur.
Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Take 2 capsules three times daily. Results are usually felt within four weeks of continuous use, and increase with longer use. Once desired results are obtained, try 1-2 capsules daily for maintenance.
INACTIVE INGREDIENT SECTION
OTHER INGREDIENTS: Fragrant waterlily (root), Vegetable capsule, Condurango (bark), Couch grass (root), European elder (fruit), Sheep sorrel (herb), Lobelia (herb).
OTHER INFORMATION: Capsule size "00". Contains no animal products, corn, soy, wheat, gluten, yeast.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN.
OTC - QUESTIONS SECTION
INDICATIONS & USAGE SECTION
USES: For relief of fibromyalgia symptoms.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Fibro Relief
NEW
An Elijah Free Formula
Homeopathic Fibromyalgia Formula
With Herbal Support
120 VEG CAPSULES
RIDGECREST HERBALS
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0272-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0565-f424-e053-dadaa90a57ce | Fibro Relief |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57520-0272-1 | Fibro Relief | 120 in 1 BOTTLE | CAPSULE | 120 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57520-0272 | FIBRO RELIEF (FERRUM METALLICUM, GUAIACUM, LITHIUM CARBONICUM, LYCOPERSICUM ESCULENTUM, MAGNESIA PHOSPHORICA) CAPSULE [APOTHECA COMPANY] | 1 | Legacy NDC, 1 package rows | 20110425_b609950f-7510-4b88-b7d8-c327be0ee96e.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GUAIACUM OFFICINALE RESIN | ACTIVE INGREDIENT | N0K2Z502R6 | 1 | |
| IRON | ACTIVE INGREDIENT | E1UOL152H7 | 1 | |
| LITHIUM CARBONATE | ACTIVE INGREDIENT | 2BMD2GNA4V | 1 | |
| MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | ACTIVE INGREDIENT | HF539G9L3Q | 1 | |
| TOMATO | ACTIVE INGREDIENT | Z4KHF2C175 | 1 | |
| GUAIACUM OFFICINALE RESIN | ACTIVE MOIETY | N0K2Z502R6 | 1 | |
| IRON | ACTIVE MOIETY | E1UOL152H7 | 1 | |
| LITHIUM CATION | ACTIVE MOIETY | 8H8Z5UER66 | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| TOMATO | ACTIVE MOIETY | Z4KHF2C175 | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| ELYMUS REPENS ROOT | INACTIVE INGREDIENT | 3IXW0F6P8W | 1 | |
| EUROPEAN ELDERBERRY | INACTIVE INGREDIENT | BQY1UBX046 | 1 | |
| LOBELIA INFLATA | INACTIVE INGREDIENT | 9PP1T3TC5U | 1 | |
| MARSDENIA CONDURANGO BARK | INACTIVE INGREDIENT | R23QIR6YBA | 1 | |
| NYMPHAEA ODORATA ROOT | INACTIVE INGREDIENT | 69RAZ4C432 | 1 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | 1 | |
| RUMEX CRISPUS ROOT | INACTIVE INGREDIENT | 9N1RM2S62C | 1 |
Products#
Every source-derived product name is available through these pages.
- Fibro Relief
- Ferrum metallicum, Guaiacum, Lithium carbonicum, Lycopersicum esculentum, Magnesia phosphorica
- IRON
- GUAIACUM OFFICINALE RESIN
- LITHIUM CARBONATE
- LITHIUM CATION
- TOMATO
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE
- MAGNESIUM CATION
- CELLULOSE, MICROCRYSTALLINE
- NYMPHAEA ODORATA ROOT
- POWDERED CELLULOSE
- MARSDENIA CONDURANGO BARK
- ELYMUS REPENS ROOT
- EUROPEAN ELDERBERRY
- LOBELIA INFLATA
- RUMEX CRISPUS ROOT
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0272 | 57520-0272-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | CAPSULE / ORAL | 2430 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DISC / EXTRACORPOREAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DROPS / ORAL | NA | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, CHEWABLE / ORAL | NA | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, DELAYED RELEASE / ORAL | 16 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE / ORAL | 29520 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | LIQUID / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / SUBLINGUAL | 4.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | SUSPENSION / ORAL | 1600 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | POWDER, FOR SUSPENSION / ORAL | 1600 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, FILM COATED / ORAL | 392 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | PASTE, DENTIFRICE / DENTAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION / ORAL | 1600 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / BUCCAL | 4.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DISC / TOPICAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e1b840f7-a357-448e-bef7-d4ed2b3a43c4 | b609950f-7510-4b88-b7d8-c327be0ee96e | 2011-04-20 | Warnings | e1b840f7-a357-448e-bef7-d4ed2b3a43c4 b609950f-7510-4b88-b7d8-c327be0ee96e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
